Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-23

Clinical Trial Update: Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain [Phase 3]

View source ↗

Summary

Phase 3 trial assessing pregabalin for diabetic peripheral neuropathy in patients using NSAIDs for other pain; study completed with posted results in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Painful Diabetic Peripheral Neuropathy | Phase 3 | Status: COMPLETED | Results posted: 2015-04-23